• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2001年至2020年希腊全国死亡率趋势:老龄化社会背景下的卫生政策影响

Nationwide mortality trends from 2001 to 2020 in Greece: health policy implications under the scope of aging societies.

作者信息

Nikolaou Maria, Theodorakis Nikolaos, Feretzakis Georgios, Vamvakou Georgia, Hitas Christos, Kalantzi Sofia, Spyridaki Aikaterini, Apostolos Anastasios, Verykios Vassilios S, Toutouzas Konstantinos

机构信息

Department of Cardiology, Sismanogleio-Amalia Fleming General Hospital, 14 25is Martiou Str., Melissia 15127, Greece; Geriatric Outpatient Clinic, Sismanogleio-Amalia Fleming General Hospital, 14 25is Martiou Str., Melissia 15127, Greece.

Department of Cardiology, Sismanogleio-Amalia Fleming General Hospital, 14 25is Martiou Str., Melissia 15127, Greece; Geriatric Outpatient Clinic, Sismanogleio-Amalia Fleming General Hospital, 14 25is Martiou Str., Melissia 15127, Greece; School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias, Athens 11527, Greece.

出版信息

Hellenic J Cardiol. 2024 Aug 28. doi: 10.1016/j.hjc.2024.08.009.

DOI:10.1016/j.hjc.2024.08.009
PMID:39214341
Abstract

OBJECTIVE

This nationwide study aims to analyze mortality trends for all individual causes in Greece from 2001 to 2020, with a specific focus on 2020, a year influenced by the COVID-19 pandemic. As Greece is the fastest-aging country in Europe, the study's findings can be generalized to other aging societies, guiding the reevaluation of global health policies.

METHODS

Data on the population and the number of deaths were retrieved from the Hellenic Statistical Authority. We calculated age-standardized mortality rates (ASMR) and cause-specific mortality rates by sex in three age groups (0-64, 65-79, and 80+ years) from 2001 to 2020. Proportional mortality rates for 2020 were determined. Statistical analysis used generalized linear models with Python Programming Language.

RESULTS

From 2001 to 2020, the ASMR of cardiovascular diseases (CVD) decreased by 42.7% (p < 0.0001), with declines in most sub-causes, except for hypertensive diseases, which increased by 2.8-fold (p < 0.0001). In 2020, the proportional mortality rates of the three leading causes were 34.9% for CVD, 23.5% for neoplasms, and 9.6% for respiratory diseases (RD). In 2020, CVD were the leading cause of death among individuals aged 80+ years (39.3%), while neoplasms were the leading cause among those aged 0-79 years (37.7%). Among cardiovascular sub-causes, cerebrovascular diseases were predominant in the 80+ year age group (30.3%), while ischemic heart diseases were most prevalent among those aged 0-79 years (up to 60.0%).

CONCLUSIONS

The global phenomenon of population aging necessitates a reframing of health policies in our aging societies, focusing on diseases with either a high mortality burden, such as CVD, neoplasms, and RD, or those experiencing increasing trends, such as hypertensive diseases.

摘要

目的

这项全国性研究旨在分析2001年至2020年希腊所有个体病因的死亡率趋势,特别关注受2019冠状病毒病大流行影响的2020年。由于希腊是欧洲老龄化速度最快的国家,该研究结果可推广至其他老龄化社会,为全球卫生政策的重新评估提供指导。

方法

从希腊统计局获取人口和死亡人数数据。我们计算了2001年至2020年三个年龄组(0至64岁、65至79岁和80岁以上)按性别划分的年龄标准化死亡率(ASMR)和特定病因死亡率。确定了2020年的比例死亡率。使用Python编程语言通过广义线性模型进行统计分析。

结果

2001年至2020年,心血管疾病(CVD)的ASMR下降了42.7%(p<0.0001),大多数亚病因呈下降趋势,但高血压疾病除外,其增加了2.8倍(p<0.0001)。2020年,三大主要病因的比例死亡率分别为:CVD占34.9%,肿瘤占23.5%,呼吸系统疾病(RD)占9.6%。2020年,CVD是80岁以上人群的主要死因(39.3%),而肿瘤是0至79岁人群的主要死因(37.7%)。在心血管亚病因中,脑血管疾病在80岁以上年龄组中占主导地位(30.3%),而缺血性心脏病在0至79岁人群中最为普遍(高达60.0%)。

结论

全球人口老龄化现象要求我们在老龄化社会中重新制定卫生政策,重点关注死亡率负担高的疾病,如CVD、肿瘤和RD,或呈上升趋势的疾病,如高血压疾病。

相似文献

1
Nationwide mortality trends from 2001 to 2020 in Greece: health policy implications under the scope of aging societies.2001年至2020年希腊全国死亡率趋势:老龄化社会背景下的卫生政策影响
Hellenic J Cardiol. 2024 Aug 28. doi: 10.1016/j.hjc.2024.08.009.
2
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
3
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家按年龄、性别划分的 264 种死因的死亡率:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9.
4
Asbestos ban policies and mesothelioma mortality in Greece.希腊的石棉禁令政策与间皮瘤死亡率
BMC Public Health. 2024 Apr 26;24(1):1177. doi: 10.1186/s12889-024-18030-x.
5
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
6
Mortality by cause for eight regions of the world: Global Burden of Disease Study.世界八个地区按病因划分的死亡率:全球疾病负担研究
Lancet. 1997 May 3;349(9061):1269-76. doi: 10.1016/S0140-6736(96)07493-4.
7
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、地区和国家按年龄、性别划分的 240 种死因的全死因和特定死因死亡率,1990-2013 年:2013 年全球疾病负担研究的系统分析。
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
8
The global burden of cardiovascular diseases and type 2 diabetes attributable to low physical activity, 1990-2019: an analysis from the global burden of disease study.1990 - 2019年全球因身体活动不足所致心血管疾病和2型糖尿病的负担:全球疾病负担研究分析
Front Cardiovasc Med. 2023 Dec 19;10:1247705. doi: 10.3389/fcvm.2023.1247705. eCollection 2023.
9
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
10
Trends of Cardiovascular Disease Mortality in Relation to Population Aging in Greece (1956 - 2015).希腊心血管疾病死亡率与人口老龄化的关系趋势(1956 - 2015年)
Open Cardiovasc Med J. 2018 Jul 31;12:71-79. doi: 10.2174/1874192401812010071. eCollection 2018.

引用本文的文献

1
From Metabolic Syndrome to Cardiovascular-Kidney-Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction.从代谢综合征到心血管-肾脏-代谢综合征及全身性代谢紊乱:呼吁认识渐进性多系统功能障碍
Anatol J Cardiol. 2025 Aug;29(8):384-393. doi: 10.14744/AnatolJCardiol.2025.5602.
2
Cardiovascular-Kidney-Metabolic Syndrome: A New Paradigm in Clinical Medicine or Going Back to Basics?心血管-肾脏-代谢综合征:临床医学的新范式还是回归基础?
J Clin Med. 2025 Apr 19;14(8):2833. doi: 10.3390/jcm14082833.
3
Barriers to Implementing Effective Healthcare Practices for the Aging Population: Approaches to Identification and Management.
实施针对老年人群的有效医疗保健措施的障碍:识别与管理方法
Cureus. 2025 Feb 24;17(2):e79590. doi: 10.7759/cureus.79590. eCollection 2025 Feb.
4
Cardiovascular-Endocrine-Metabolic Medicine: Proposing a New Clinical Sub-Specialty Amid the Cardiometabolic Pandemic.心血管-内分泌-代谢医学:在心脏代谢大流行背景下提出一个新的临床亚专业。
Biomolecules. 2025 Mar 5;15(3):373. doi: 10.3390/biom15030373.
5
From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework.从心血管-肾脏-代谢综合征到心血管-肾脏-肝脏-代谢综合征:提出一个扩展框架。
Biomolecules. 2025 Feb 2;15(2):213. doi: 10.3390/biom15020213.
6
Integrated Management of Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Expanding Roles of SGLT2is, GLP-1RAs, and GIP/GLP-1RAs.心血管-肾脏-肝脏-代谢综合征的综合管理:钠-葡萄糖协同转运蛋白2抑制剂、胰高血糖素样肽-1受体激动剂及胃抑肽/胰高血糖素样肽-1受体激动剂的作用拓展
Biomedicines. 2025 Jan 8;13(1):135. doi: 10.3390/biomedicines13010135.
7
Growth Hormone and Heart Failure: Implications for Patient Stratification, Prognosis, and Precision Medicine.生长激素与心力衰竭:对患者分层、预后及精准医学的影响
Diagnostics (Basel). 2024 Dec 16;14(24):2831. doi: 10.3390/diagnostics14242831.
8
Ghrelin: An Emerging Therapy for Heart Failure.胃饥饿素:一种心力衰竭的新兴治疗方法。
Clin Endocrinol (Oxf). 2025 Apr;102(4):403-412. doi: 10.1111/cen.15196. Epub 2025 Jan 5.
9
GH Therapy in Chronic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.生长激素疗法治疗慢性心力衰竭:随机对照试验的系统评价与荟萃分析
J Clin Endocrinol Metab. 2025 Mar 17;110(4):e1252-e1260. doi: 10.1210/clinem/dgae814.
10
Immunosenescence: How Aging Increases Susceptibility to Bacterial Infections and Virulence Factors.免疫衰老:衰老如何增加对细菌感染和毒力因子的易感性。
Microorganisms. 2024 Oct 11;12(10):2052. doi: 10.3390/microorganisms12102052.